Analysts: Natus Medical Inc (BABY.OQ)
BABY.OQ on NASDAQ Stock Exchange Global Select Market
13.64USD
1 Aug 2013
13.64USD
1 Aug 2013
Price Change (% chg)
$0.85 (+6.65%)
$0.85 (+6.65%)
Prev Close
$12.79
$12.79
Open
$12.95
$12.95
Day's High
$13.81
$13.81
Day's Low
$12.52
$12.52
Volume
103,032
103,032
Avg. Vol
56,306
56,306
52-wk High
$15.18
$15.18
52-wk Low
$9.65
$9.65
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 0.17 | December | 1 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | 0 |
| (2) OUTPERFORM | 2 | 2 | 2 | 1 |
| (3) HOLD | 3 | 3 | 3 | 3 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.60 | 2.60 | 2.60 | 2.75 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 4 | 85.20 | 89.90 | 82.20 | 88.10 |
| Quarter Ending Dec-13 | 4 | 95.05 | 99.40 | 88.20 | 98.73 |
| Year Ending Dec-13 | 5 | 352.21 | 364.50 | 337.60 | 349.67 |
| Year Ending Dec-14 | 4 | 366.21 | 378.70 | 348.60 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 4 | 0.17 | 0.22 | 0.14 | 0.21 |
| Quarter Ending Dec-13 | 4 | 0.29 | 0.33 | 0.26 | 0.28 |
| Year Ending Dec-13 | 4 | 0.75 | 0.87 | 0.65 | 0.81 |
| Year Ending Dec-14 | 3 | 0.89 | 0.95 | 0.85 | -- |
| LT Growth Rate (%) | 3 | 16.00 | 22.00 | 11.00 | 18.50 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 84.47 | 85.83 | 1.37 | 1.62 |
| Quarter Ending Dec-12 | 93.60 | 90.45 | 3.15 | 3.37 |
| Quarter Ending Sep-12 | 81.40 | 80.72 | 0.68 | 0.84 |
| Quarter Ending Jun-12 | 61.50 | 61.01 | 0.49 | 0.79 |
| Quarter Ending Mar-12 | 58.04 | 59.51 | 1.47 | 2.53 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.10 | 0.15 | 0.05 | 42.86 |
| Quarter Ending Dec-12 | 0.26 | 0.29 | 0.03 | 10.14 |
| Quarter Ending Sep-12 | 0.13 | 0.15 | 0.02 | 12.53 |
| Quarter Ending Jun-12 | 0.12 | 0.12 | 0.00 | 2.83 |
| Quarter Ending Mar-12 | 0.05 | 0.07 | 0.02 | 40.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 85.20 | 85.20 | 89.88 | 89.63 | 88.10 |
| Quarter Ending Dec-13 | 95.05 | 95.05 | 99.95 | 99.80 | 98.73 |
| Year Ending Dec-13 | 352.21 | 352.21 | 363.98 | 363.62 | 349.67 |
| Year Ending Dec-14 | 366.21 | 366.21 | 375.73 | 375.26 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.17 | 0.17 | 0.20 | 0.20 | 0.21 |
| Quarter Ending Dec-13 | 0.29 | 0.29 | 0.32 | 0.32 | 0.28 |
| Quarter Ending Dec-13 | 0.75 | 0.75 | 0.86 | 0.85 | 0.81 |
| Quarter Ending Dec-14 | 0.89 | 0.89 | 0.94 | 0.94 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 3 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 3 |
| Year Ending Dec-13 | 0 | 0 | 0 | 3 |
| Year Ending Dec-14 | 0 | 0 | 0 | 2 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 3 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 3 |
| Year Ending Dec-13 | 0 | 0 | 0 | 3 |
| Year Ending Dec-14 | 0 | 0 | 0 | 2 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates